Vaspin and omentin are adipose tissue adipokines that have often been related to obesity and its comorbidities. The aim of this study was to investigate the behaviour of serum omentin and vaspin in models of type 2 diabetes. To do this, Wistar rats (~200 g) were randomly divided into two groups: a non-diabetic group (n = 6) and a diabetic group fed on a high-fat diet (n = 6) and a low dose of streptozotocin (Sigma â ). All procedures were approved by the Brazilian Ethics Committee. Body weight (BW) and food intake were recorded daily. Tail blood glucose levels were assessed at the end of the diabetes induction period. The insulin tolerance test (ITT) was performed after the diabetes induction period (7 weeks). The serum and tissues (liver, pancreas, and retroperitoneal (RET), epididymal (EPI) and visceral (VIS) white adipose tissues) were immediately removed and weighed. Analyses of levels of insulin, omentin, vaspin, adiponectin and inflammatory cytokines IL-6, IL-8 (CXCL8), TNF-a and C-reactive protein (CRP) in serum were performed using the enzyme-linked immunosorbent assay (ELISA). Our results showed that IL-8 and CRP serum levels in the diabetic group were significantly higher than in the non-diabetic group. Vaspin and adiponectin values were lower for the diabetic group than for the non-diabetic group. Omentin, IL-6 and TNF-a values did not differ between the groups. Our results showed that both the metabolism of the adipose tissue and the secretion of adipokines may be affected in diabetic rats. Omentin showed no difference between the groups, although the vaspin values decreased in the diabetic group.
SUMMARY
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For decades it was believed that adipose tissue was merely a site of fat storage. However, today it is clear that adipose tissue is also an endocrine organ that secretes and releases into circulation adipokines and peptides with autocrine, paracrine and hormonal functions . Adipose tissue produces a number of adipokines, which play important roles in modulating energy homoeostasis and insulin sensitivity. In this context, vaspin (visceral adipose tissue-derived serine protease inhibitor) and omentin are considered new identified adipokines, mainly produced by adipose tissue and also related to obesity and its comorbidities.
Vaspin was first described as a member of the serine protease inhibitor (serpin) family, which is highly expressed in visceral adipose tissue of obese OLETF (Otsuka Long-Evans Tokushima Fatty) rats, an animal model of type 2 diabetes (Hida et al. 2005) . In diabetic or insulin-resistant individuals, the vaspin levels are usually high, when compared to normal individuals with low weight (Li et al. 2008) . Additionally, recent research has concluded that vaspin has a modulatory role in glucose metabolism (Wada 2008) , but the mechanism of this is not very clear. These findings may lead to the future development of new therapies using vaspin analogues or antagonists so as to improve insulin sensitivity in metabolic syndrome.
Concerning omentin, it is preferably expressed in visceral adipose tissue (visceral vascular stroma cells) which is negatively associated with insulin resistance and obesity. Omentin enhances the effect of insulin on glucose metabolism (Yang et al. 2006) . Moreover, once in the bloodstream, it could also play an endocrine role in tissues, such as liver and muscle, enhancing insulin sensitivity (MorenoNavarrete et al. 2010) . Thus the modulatory role of vaspin mentioned above has to take into account that in type 2 diabetes there is a relationship to changes in insulin sensitivity in peripheral tissues, such as liver muscle, which is followed by the decrease in insulin secretion, that is asociated with progressive damage to the pancreas (Petersen & Shulman 2002) . As possible indicators of this condition, lower glucose tolerance, hyperglycaemia and reduced glycogen reserves have been observed as a result of glucose uptake deficiency (Saltiel & Kahn 2001; Avramoglu et al. 2006) . The changes observed in the pancreas are related to decreased beta cells (b) and deformities, mainly in the cytoarchitecture of the islets of Langerhans, as well as an irregular distribution of other cell types, such as lymphocytes infiltrating the islets. This infiltration may be the cause of progressive destruction of the cells in patients with type 2 diabetes (Kessler et al. 1999) .
In the context of diabetes, model animals of type 2 diabetes have provided an opportunity to study this disease extensively. Many models with genetic changes induced by drugs or by altering the diet are being tested, but the main challenge is to simulate as closely as possible the type 2 diabetes that is found in humans (Wilson & Islam 2012) . Induction of diabetes by streptozotocin (STZ) is widely used to study the pathophysiology of this syndrome. The experimental model, which combines a high-fat diet with a low dose of STZ, is also used considering its ability to produce insulin resistance and cause the initial dysfunction of beta cells with subsequent non-genetic hyperglycaemia (Srinivasan et al. 2005) . This model approximates the natural state of the pathology, as well as the metabolic characteristics of type 2 diabetes observed in humans.
It is known that damage can be caused to the pancreas and liver in induced diabetic rats with low doses of STZ and highfat diet (Srinivasan et al. 2005; Srinivasan & Ramarao 2007) , but little is known about the metabolism of adipose tissue and the behaviour of adipokines in this experimental model. Indeed, there are few reports that show the behaviour of these adipokines, specifically vaspin and omentin, in experimental diabetes models. Therefore, in this study we investigated the serum levels of omentin and vaspin and their relation to inflammation in obesity-related type 2 diabetes in an experimental model for type 2 diabetes associated with a high-fat diet and a low dose of STZ.
Materials and methods

Animals
Wistar strain albino rats (200 g) were obtained from the Central Vivarium at the Federal University of São Carlos and were kept in an individual cage with food and water ad libitum, on a 12/12-h light-dark cycle at 25 AE 1°C. The animals were acclimatized for a week in laboratory conditions before experimentation. All the procedures were approved by the Ethics Committee at the Federal University (Protocol number 008/2013).
The animals were randomly divided into two groups in accordance with the type of food intake for diabetes induction: the non-diabetic group -rats were fed a standard diet (n = 6); and the diabetic group -rats were fed a high-fat diet (n = 6) associated with a low dose of streptozotocin (Sigma â ). After 4 weeks of eating a hyperlipidic diet, an intraperitoneal dose of streptozotocin (Sigma â , SigmaAldrich, St. Louis, MO, USA) 35 mg/kg BW (pH 4.4 streptozotocin in citrate solution) was administered, with previous fasting. The control rats received one single application of a citrate solution vehicle ( Figure 1 ). Diabetic animals were considered those with glycaemic levels ≥250 mg/dl (Srinivasan et al. 2005) .
Ethical approval statement
This study was approved by the Ethical Committee of Experimental Animals of the Federal University of São Carlos (protocol n°008/2013).
Diets
The standard diet consisted of an MP-77 standard rat chow diet (in pellet form), provided by Primor (São Paulo, Brazil), which contained 23 g of protein (per 100 g diet), 49 g of carbohydrate, 4 g of total fat, 5 g of fibre, 7 g of ash and 6 g of vitamins. The high-fat diet consisted of the MP-77 standard chow plus peanuts, milk chocolate and sweet biscuits. All the components were in powdered form and mixed at a proportion of 3:2:2:1. Each 100 g of the high-fat diet contained 20% of protein, 20% of fat, 48% of carbohydrate and 4% of fibre. The caloric density of the diets was determined by an adiabatic calorimeter (IKAC400). The caloric density values were 5.12 kcal/g for the high-fat diet and 4.07 kcal/g for the standard diet (Estadella et al. 2004; Duarte et al. 2008) .
Measurements
Body weight and food intake were recorded daily. Food intake was calculated by the difference in weight between the offered diet and the weight of the rest of the diet. Blood glucose levels were assessed using an Accu-Check glucose meter (Roche Diagnostics, Indianapolis, IN, USA) by the tail of the animal at the end of the diabetes induction period.
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Insulin tolerance test
An ITT was performed after the diabetes induction period (7 weeks). After overnight fasting, the rats were administered an intraperitoneal injection (with no previous anaesthesia) of human insulin (1 U/kg of BW). Blood samples were obtained from the tail vein before injection, and subsequently after an insulin injection (0, 15, 30 and 45 min after injection) (Ropelle et al. 2006) .
Experimental procedure
At the end of the 7-week experimental period, all the animals were euthanized by decapitation. The blood was immediately collected and centrifuged, and aliquots of the serum were frozen at 80°C for subsequent analyses. The liver, pancreas and white adipose tissue depots, retroperitoneal (RET), epididymal (EPI) and visceral (VIS), were removed immediately and weighed by procedures adapted for rats Sene-Fiorese et al. 2008) , using the anatomical localization of the organs previously described by Cinti (2005) .
Biochemical analyses
Serum was obtained by centrifugation of blood samples, and the aliquots were used to measure triacylglycerols, cholesterol and high-density lipoprotein-cholesterol (HDL-C) (commercial kit from Labtest Diagnostics S.A., Minas Gerais, Brazil).
Pancreas histology
Pancreatic tissue was hydrated and then cut into 7.0-lm sections, fixed in 10% formalin and paraplast-embedded. Histologic procedures followed the methodology described in Rashid and Sil (2015) , and histologic sections were stained by the regular haematoxylin-eosin (HE) method. The stained sections were examined and photographed under a light microscope.
Determination of insulin, omentin, vaspin, adiponectin and inflammatory cytokines
Quantification of insulin, omentin, vaspin, adiponectin and inflammatory cytokines in serum was performed using the enzyme-linked immunosorbent assay (ELISA) kit. Interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-a) were evaluated using commercial kits of OptEIA (BD Biosciences PharMingen, San Diego, CA, USA). Adiponectin, IL-8 and C-reactive protein (CRP) levels were analysed using DuoSet kits (R&D Systems, 614 McKinley Pl NE, Minneapolis, MN, USA). The omentin and vaspin values were obtained with Rat EIA-OME and EIA-VAP (RayBiotech â , Norcross, GA, USA). Quantitative measurements of rat insulin in serum were taken using the Abnova kit (Abnova Corporation, Taipei, Taiwan). All the used kits followed the producer's recommendations, and the results were expressed in pg/ml or ng/ml.
Statistical analysis
Statistical analysis was performed in unpaired and paired Student's t-tests. Data were analysed using a statistical software package (SigmaStat version 3.5; SYSTAT) and presented as means AE SEM (P < 0.05 was considered statistically significant). Figure 2 shows the body mass (a), food intake (b) and energy intake (c) over 7 weeks. Although the body mass values were higher in the sixth and seventh weeks (Figure 2a ) in the diabetic group when compared to the non-diabetic group, the food intake was not significantly different between the two groups ( Figure 2b ). The energy intake was higher in the diabetic animals every week; only the fourth-week consumption was similar. Table 1 shows the metabolic variables in both groups during the whole experimental period (Figure 1 ). Triglycerides (mg/dl), cholesterol (mg/dl), HDL-C (mg/dl) and final glucose (mg/dl) were increased in the diabetic group compared to the non-diabetic group, but the initial glucose was not significantly different between the groups. Insulin levels in the diabetic group showed lower values when compared to the non-diabetic group. Table 2 . Pancreas mass values were reduced in the diabetic group when compared to the nondiabetic group. The values observed for adipose tissues, VIS, RET and EPI, were higher in the diabetic group when compared to the non-diabetic group.
Results
Food intake and body mass
Metabolic variables
Insulin tolerance test and area under the curve Figure 3 shows the results of the IIT and the area under the curve. The IIT demonstrates a decline of 52% in the nondiabetic group, while in the diabetic group there is a decline of 38%. The area under the curve shows the increase found in the diabetic group compared to the non-diabetic group.
Serum cytokines
The data for serum interleukin-6 (IL-6), interleukin-8 (IL-8, CXCL8), tumour necrosis factor-alpha (TNF-a) and CRP values are presented in Figure 4 . There are no significant differences in IL-6 (Figure 4a ) and TNF-a (Figure 4b ) between the groups. On the other hand, the IL-8 (Figure 4c ) and CPR ( Figure 4d ) values were greater in the diabetic group compared to the non-diabetic group (Figure 4c,d ).
Serum levels of adipokines
Figure 5(a) shows that vaspin values were lower for the diabetic group when compared to the non-diabetic group. Data are shown as mean AE SEM (n = 6; *P < 0.05 vs. non-diabetic). Figure 2 Body mass gain (kg), food intake (g) and energy intake (Kcal/ weeks) over the 7-week experimental period. Data are shown as the mean values AE SEM (n = 6; a P < 0.05 vs. non-diabetic). However, omentin values for the diabetic group were significantly higher than the values observed in the non-diabetic group (Figure 5b ). Adiponectin levels were significantly reduced in the diabetic group compared to the non-diabetic group (Figure 5c ).
Histology of pancreatic tissue
The histologic micrograph analyses of pancreatic tissues are presented in Figure 6 . For the non-diabetic group, a normal lobular architecture in the pancreatic tissue (Figure 6a ) was observed. On the other hand, Figure 6 (b) shows a reduced area and distorted forms of islets of Langerhans, as well as the presence of inflammatory cells.
Discussion
STZ is a drug widely used to induce experimental diabetes mellitus in animals. Its diabetogenic action occurs by the irreversible damage to pancreatic beta cell resulting in the loss of cellular functionality to produce and release insulin. Thus, the reduction in size of islets, resembling the findings in type 1 diabetic animals was observed due to toxic and harmful action of STZ on the pancreatic beta cells (Fadillioglu et al. 2008; Punithavathi et al. 2008; Zafar & Naqvi 2010) , and was also observed in this study. It is known that using the experimental model for type 2 diabetes mellitus which combines a high-fat diet and low doses of STZ, is considered an effective way of achieving resistance to insulin action. It also causes beta cell dysfunction at the beginning of the pathology and subsequent non-genetic hyperglycaemia (Srinivasan et al. 2005; Wilson & Islam 2012) . In fact, in our study, pancreatic islets (after applying low doses of STZ) showed a partial change in the beta cells, with significant morphological changes, including a breakdown of micro-anatomical features, inflammatory infiltration and degenerated cells with pyknotic nuclei (Figure 6 ). It is noteworthy that the model used in this study approximates the natural state of the pathology, as well as the metabolic characteristics of type 2 diabetes mellitus in humans. In this context, we observed greater body mass gain in the diabetic group, as well as a significant increase in the fat depots. In this case, it is important to consider that in the high-fat diet group, caloric intake by rats is higher than in the standard diet animal group, which represents a higher contribution to fat deposition (Srinivasan & Ramarao 2007) , as observed by the differences between the weight of the fat depots found in our diabetic animals.
Experimental studies have demonstrated that high-fat diet consumption causes metabolic changes already in the third week of change in diet intake . This might explain the increase in triglycerides values, cholesterol and blood glucose in the diabetic group after 7 weeks of eating a high-fat diet, as already described in other studies (Srinivasan et al. 2005; Mu et al. 2006; Wilson & Islam 2012) . Even in a high-fat diet, the food intake was similar for both groups, but the total caloric intake was greater in the high-fat-diet, which shows a better metabolic efficiency of this diet, as reported previously in other studies Sene-Fiorese et al. 2008) . Indeed, pancreatic changes and the dyslipidaemic profile may also be related to the inflammatory profile observed. Studies have shown the direct involvement of plasma cytokines expressed by the adipose tissue, with glucose metabolism and diabetes (Ouchi et al. 2011; Derosa et al. 2013; Flehmig et al. 2014) .
In the context of inflammation, the levels of inflammatory chemokine IL-8 (CXCL8) and CPR were higher (Figure 4 ), but the concentrations of IL-6 and TNF-a were not altered (Figure 4 ) in the diabetic group. Although TNF-a values were higher in the diabetic groups, there were no statistical differences. It is known that the TNF-a is a pro-inflammatory cytokine that is primarily produced by monocytes and macrophages and plays an important role in inflammatory and autoimmune diseases (Lee et al. 2013) . In experimental models of obesity and type 2 diabetes, TNF-a expression increased in adipose tissues (Hotamisligil et al. 1993; NietoVazquez et al. 2008) . Thus, these statements emphasize the importance of our findings as IL-6 is a pro-inflammatory cytokine that may also be involved in insulin resistance and associated with obesity. Besides the inflammatory state promoted by type 2 diabetes, the high and inadequate caloric intake can also influence the accumulation of fat in adipose tissue, causing fat cell hypertrophy. This hypertrophy is related to hypoxia cases, such as the higher oxidative stress and the activation response of endoplasmic reticulum stress, which leads to an increase in inflammatory cytokines such as IL-6 and TNF-a. These cytokines may imply an increase in insulin resistance in fat, muscle and hepatic cells, which are associated with the systemic changes of insulin sensibility and glucose homoeostasis.
Higher levels of pro-inflammatory cytokines promote a release of CRP. In the initial phase of type 2 diabetes, CRP is already present and their serum concentrations increase as the disease progresses (Festa et al. 2002; Hu et al. 2004) . Therefore, these pathways lead to higher levels of pro-inflammatory cytokines of an acute phase (IL-6 and TNF-a), which promotes a release of IL-8 (CXCL8) (Fain 2010) . This study corroborates our results, where the CRP and IL-8 levels were higher in the diabetic group (Figure 4) . The increase in IL-8 and CRP shows that recruitment of inflammatory cells in the tissues associated with abdominal obesity is probably taking place. All these facts contribute to increasing the inflammatory process, as well as injuries associated with type 2 diabetes in this model.
Considering the immune response, omentin, vaspin and adiponectin are adipokines secreted by adipose tissue. Some studies show that omentin produces beneficial metabolic effects and also plays an important anti-inflammatory role in chronic diseases as occurs in obesity and diabetes (Hern andez-D ıaz et al. 2016) . Studies show that omentin-1 can be significantly reduced in obese mice when compared to non-obese ones (Feng et al. 2013 ). However, in other studies, these results were similar between obese and nonobese groups (Derosa et al. 2013) . According to Akbarzadeh et al. (2014) , an increase in omentin serum was observed in rats with experimental diabetes induced by STZ. Nevertheless, the exact role of omentin is not well described in the literature. In our study specifically, omentin did not differ between the groups. There is a lack of studies regarding vaspin effects.
So far it is known that in rats, it is expressed in adipocytes from visceral white adipose tissues and it improves insulin sensitivity in mice (Auguet et al. 2011) . The expression of vaspin in visceral adipose tissue, found in Wistar rats after a hypercaloric diet, induced obesity and insulin resistance (Heiker 2014 ). In the current study, we found a decrease in circulating vaspin in the diabetic group. This may have occurred due to insulin concentration, as other studies have shown a close relationship between them. Indeed, Wada (2008) showed that the administration of vaspin improved insulin sensitivity in rats fed on a high-fat diet. Moreover, Hida et al. (2005) showed that vaspin administration in rats promoted an improvement in insulin sensitivity and glucose tolerance. In conclusion, vaspin can exert a great potential in insulin sensitivity, but the mechanisms that underlie its pathways are still not clear. In our experimental model, it seems that inflammation contributes to the upregulating vaspin in diabetic mice, suggesting that this protein may contribute to the construction of the phenotype of this type 2 diabetes model.
Vaspin may also be related to serum levels of other important adipokines such as adiponectin. Hida et al. (2005) showed that recombinant vaspin administration increases adiponectin concentrations. Adiponectin and vaspin are related to an increase in sensitivity to insulin and a reduction in glucose intolerance in diabetes (Trujillo & Scherer 2005) , and both are reduced in type 2 diabetes (Ouchi et al. 2011) . Studies have shown that the action of adiponectin is closely related to its effect on the sensitivity to insulin in diabetic animals (Saad et al. 2015) and plays an important role in inflammation (Cao 2014) . However, its exact influence or its relationship with the adipocytokines, such as vaspin and omentin, in obese individuals with type 2 diabetes is still unclear and further research is needed to clarify these facts. Thus, omentin and vaspin have gained prominence in research to elucidate the signalling pathways present in diabetes, and they may evolve to be used as a possible alternative treatment in type 2 diabetes, targeting metabolic and glucose tolerance disorders (Dimova & Tankova 2015) .
Our results provide evidence that both metabolism of adipose tissue and adipokine secretion can be affected in diabetic rats. Omentin has shown no changes in either groups, but the vaspin values decreased in the diabetic group. These results in diabetic rats induced with a highfat diet and low dose of STZ can be associated with insulin resistance. Further investigations into the molecular links between vaspin and diabetes may unravel innovative therapeutic strategies in diabetes. Moreover, up-and downregulation of vaspin and omentin suggests that these biomarkers can contribute to a phenotype in type 2 diabetes.
